期刊档案 · Medicine-Infectious Diseases

Indian Journal of Tuberculosis

ISSN 0019-5707 · eISSN 2589-1278 · Tuberculosis Association of India

Indian Journal of Tuberculosis 订阅期刊,近 24 个月 116 篇文章投稿到接收中位 68 天,2025 年发文 152 篇,Scopus 收录。

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区Q3Infectious Diseases · 排名 249/361
审稿周期68 天投稿到接收中位数 · 近 24 个月 116 篇文章 · PubMed
版面费—未从任何来源获得费用信息
录用比例—暂无反馈
年发文量152 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Indian Journal of Tuberculosis 由 Tuberculosis Association of India 出版。按 OpenAlex 近年发文统计,该刊主要发表 Tuberculosis Research and Epidemiology、Infectious Diseases and Tuberculosis、Diagnosis and treatment of tuberculosis 等主题的论文,这 3 个主题约占 71.6%。(根据 OpenAlex 主题统计与中科院分区数据生成)

Indian Journal of Tuberculosis (IJTB) is an international peer-reviewed journal devoted to the specialty of tuberculosis and lung diseases and is published quarterly. IJTB publishes research on clinical, epidemiological, public health and social aspects of tuberculosis.The journal accepts original research articles, viewpoints, review articles, success stories, interesting case series and case reports on patients suffering from pulmonary, extra-pulmonary tuberculosis as well as other respiratory diseases, Radiology Forum, Short Communications, Book Reviews, abstracts, letters to the editor, editorials on topics of current interest etc.The articles published in IJTB are a key source of information on research in tuberculosis. The journal is indexed in Medline

摘自期刊官网 Aims & Scope

研究方向(LetPub):Medicine-Infectious Diseases

编委会国家分布:未见中国大陆编委;主要国家 印度 8、瑞士 4、加拿大 3、美国 1、日本 1(共 17 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Tuberculosis Research and EpidemiologyMedicine38.3%
  2. Infectious Diseases and TuberculosisMedicine20.6%
  3. Diagnosis and treatment of tuberculosisMedicine12.7%
  4. HIV, TB, and STIs EpidemiologySocial Sciences6%
  5. Mycobacterium research and diagnosisMedicine2.9%
  6. Healthcare Systems and ReformsEconomics, Econometrics and Finance2.4%
  7. Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine1.4%
  8. HIV/AIDS Research and InterventionsMedicine1.2%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

CiteScore 分区(Scopus,2026 年 6 月版)

学科分区排名百分位
Infectious DiseasesQ3249/361—

Scopus 按 CiteScore 在每个学科内为期刊排名,百分位 75 及以上为 Q1,每 25 为一档;与中科院分区是不同体系。LetPub

数据库收录

ScopusLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

MEDLINE出版商官网

其他:IndMED

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

CiteScore 2026-06
1.9LetPub ·
CiteScore(出版商公布)
1.9出版商官网 ·
SJR 2026-06
0.4LetPub ·
SNIP 2026-06
0.81LetPub ·
h-index
36OpenAlex ·
i10-index
288OpenAlex ·
两年平均被引
1.03OpenAlex ·
Gold OA 文章占比
0%LetPub ·

逐年发文量 OpenAlex 统计 · 累计 1,650 篇 · 当年数据不完整

年份发文量其中 OA被引
202616641,210
202515221,455
202412011,381
202315351,400
20228891,296
2021159291,048

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

68 天投稿到接收中位数 · P25–P75 36 天 – 95 天

接收到上线
中位数 1 天(116 篇)
投稿到上线
中位数 69 天
样本
116 篇有投稿与接收日期的文章(窗口内共 299 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

投稿到接收
77 天出版商官网 ·
接收到发表
2 天出版商官网 ·
评审方式
单盲同行评审出版商官网

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

订阅期刊LetPub

订阅期刊,文章需订阅或购买阅读,通常不收取版面费。

尚未从任何来源获得费用信息,请以期刊官网为准。

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

接收的文章类型7 种,含篇幅限制
  1. editorialThese are usually written by invited authors or editorial board members and are comments on recent news or articles published in the Journal.Format guide• Word …正文 ≤ 1,500 词
  2. letteronclusions reached in the article. Such letters can be up to a text of 1000 words with two tables/figures and 10 references. Only the most im正文 ≤ 1,000 词
  3. letters to the editorLetters are welcome in response to previously published IJTB articles, and may also include interesting cases that do not meet the requirement of being truly ex…正文 ≤ 500 词 · 图表 ≤ 1
  4. original articleThese articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal studies, cohort studi…正文 ≤ 3,000 词 · 摘要 ≤ 500 词
  5. perspectiveThese are comments on recent news or ground-breaking work and should provide a short review of the current state of research and explain the importance of the n…正文 ≤ 1,200 词
  6. review articleThese should aim to provide the reader with a balanced overview of an important and topical subject in Rheumatology medicine, emphasizing factors such as cause,…正文 ≤ 3,500 词 · 摘要 ≤ 500 词
  7. short communicationThese reports should be concise presentations of preliminary experimental results or technical aspects of clinical or experimental practice that are not fully i…正文 ≤ 1,500 词 · 摘要 ≤ 500 词 · 图表 ≤ 1
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、同行评审、预印本
AI 使用 Declaration of generative AI use

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Group authorship

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

原文 ↗出版商官网 ·
出版伦理

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy. 模型摘要

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

原文 ↗出版商官网 ·
许可与版权 Copyright

The Indian Journal of Tuberculosis (IJTB), formerly, Journal of Tuberculosis Association of India is the official, peer-reviewed publication of the Tuberculosis Association of India. Manuscripts published in the IJTB become the permanent property of the Tuberculosis Association of India. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduc…

原文 ↗出版商官网 ·
同行评审 Peer review

Single anonymized review process; submissions initially assessed by editors; if suitable, sent to a minimum of one reviewer; editors make the final decision. 模型摘要

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…

原文 ↗出版商官网 ·
预印本 Preprints

Preprint sharing is allowed in line with Elsevier's article sharing policy and does not count as prior publication. 模型摘要

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Tuberculosis Association of India
ISSN
0019-5707
电子版 ISSN
2589-1278
学会 / 主办单位
Tuberculosis Association of India
官方链接

常见问题

关于 Indian Journal of Tuberculosis 的常见问题

Indian Journal of Tuberculosis 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)116 篇已发表文章登记的日期,投稿到接收的中位数为 68 天(四分位 36–95 天)。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Indian Journal of Tuberculosis 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 17 位编委中,没有中国大陆学者;人数最多的国家是 印度(8 位)、瑞士(4 位)、加拿大(3 位)。统计按编委会页面列出的机构国家计,仅供参考。

Indian Journal of Tuberculosis 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Indian Journal of Tuberculosis 被 Scopus 收录。期刊官网自述还被 MEDLINE 收录,该清单未与各数据库逐一核对。

Indian Journal of Tuberculosis 是开放获取期刊吗?版面费多少?

Indian Journal of Tuberculosis 为订阅期刊。费用信息尚未获得,请以官网为准。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-30 归档)。最近更新:。